Gemcitabine/Cisplatin Versus Gemcitabine/Epirubicin for Non-Small Cell Lung Cancer (NSCLC)
Clinical trial NCT00154739 · COMPLETED
Trial details
- NCT number
- NCT00154739
- Sponsor
- National Taiwan University Hospital
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 1998-10-01
- Primary completion
- 2005-07-01
- Enrollment
- 86
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.